Ricerca avanzata

Il dottor Colin S. Goldschmidt, MD, è un amministratore delegato di Douglass Hanly Moir Pathology Pty Ltd. e un amministratore delegato, MD & Executive Director di Sonic Healthcare Ltd. Fa parte del consiglio di amministrazione di Sonic Healthcare Holding Co., Sonic Healthcare Ltd., Health Services Laboratories LLP, Sonic Healthcare USA, Inc., TDL Genetics Ltd. e The Doctors Laboratory Ltd. Il Dr. Goldschmidt è stato precedentemente impiegato come direttore non esecutivo presso Independent Practitioner Network Pty Ltd. e come direttore non esecutivo indipendente presso Silex Systems Ltd.

Attualmente, Peter Goldschmidt occupa la posizione di presidente del consiglio esecutivo di STADA Arzneimittel AG, amministratore delegato di Fougera Pharmaceuticals, Inc. e presidente di Sandoz, Inc. È anche nel consiglio dell'Associazione per i farmaci accessibili. In precedenza ha ricoperto la posizione di Head-Marketing presso Novartis Pharma (Sweeden), Country President presso Novartis Healthcare Philippines, Inc, Head-Central & Eastern Europe presso Sandoz International GmbH e Head-Sales & Marketing presso Novartis Pharmaceuticals. Peter Goldschmidt ha conseguito una laurea e un diploma di laurea presso l'Università di Mnster.

Colin J. Meyer è Chief Research & Development Officer, Executive VP presso Reata Pharmaceuticals, Inc. Ha conseguito una laurea presso l'Università della Virginia, un dottorato presso l'Università del Texas Southwestern Medical Center e un MBA presso la SMU-Cox School of Business.

Colin Peter Kilty è nel consiglio della Red Deer Regional Health Foundation e Senior VP-Operations, Retail & Commercial Fuels alla Parkland Corp. In passato ha ricoperto la posizione di presidente della Providence Healthcare, di presidente della Canadian Independent Petroleum Marketers Association e di vicepresidente senior delle operazioni di vendita alla Canadian Tire Corp. Ltd. e Presidente della Canadian Tire Petroleum, Inc. (una filiale della Canadian Tire Corp. Ltd.). Il signor Kilty ha conseguito una laurea presso la University of Western Ontario e un MBA presso la Schulich School of Business.

Attualmente, Colin Bond è presidente non esecutivo di European ScreeningPort GmbH e direttore finanziario di Vifor Pharma AG, direttore finanziario di Vifor Pharma Management AG (una controllata di Vifor Pharma AG). È anche nel consiglio di Siegfried Holding AG, Vifor Fresenius Medical Care Renal Pharma Ltd. e BioPharma Credit PLC e membro della Royal Pharmaceutical Society of Great Britain. Colin Bond ha occupato in precedenza la posizione di direttore finanziario di Evotec SE, direttore finanziario di Great Lakes Chemical Corp., direttore finanziario di Novelis AG, direttore finanziario di Novelis Europe Holdings Ltd., direttore finanziario di Jet Aviation Management AG, direttore finanziario di Ecolab (Schweiz) GmbH, revisore di PricewaterhouseCoopers LLP, revisore di Arthur Andersen AG e revisore di Procter & Gamble AG. Colin Bond ha ricevuto un MBA dalla London Business School e una laurea presso l'Università di Aston.

Colin D. Meadows è Senior MD & Head-Private Markets presso Invesco Ltd. Fa parte del consiglio di amministrazione di Invesco Mortgage Capital, Inc. e Atlantic Trust Co., NA (Georgia). Si è laureato alla Andrews University e si è laureato alla Harvard Law School.

Colin S. Mooney ricopre la posizione di Chief Digital Officer & Senior Vice President presso Robert Half International, Inc.

Colin Moore è Global Chief Investment Officer & Executive VP di Ameriprise Financial, Inc. e Global Chief Investment Officer & Executive VP di Columbia Cent Clo Advisers, LLC, Global Chief Investment Officer di Columbia Wanger Asset Management LLC, Global Chief Investment Officer di Columbia Management Investment Advisers LLC e Global Chief Investment Officer di Columbia Threadneedle Investments (Missouri) (che sono tutte controllate di Ameriprise Financial, Inc.) Colin Moore è anche vicepresidente senior di Tri-Continental Corp. e vicepresidente senior di Columbia Seligman Premium Technology Growth Fund, Inc. In passato ha occupato la posizione di Chief Investment Officer presso Columbia Management Advisors, Inc., Portfolio Manager presso Putnam Investment Management LLC, Director of Research presso Rockefeller & Co., Inc. e Head of Investments presso Banc of America Capital Management LLC.

Mr. Colin R.
Day is a Non-Executive Chairman at Premier Foods Plc and a Secretary & Director at Flyglass Ltd.
He is on the Board of Directors at S4 Capital Plc, Factory Mutual Insurance Co., Meggitt Ltd., FM Global Ltd., Flyglass Ltd., Affiliated FM Insurance Co. (Canada), Factory Mutual Insurance Co. (Quebec), Fm Global, Inc., FMIC Holdings, Inc., MK:U Ltd., Cranfield University and United Kingdom Ministry of Environment, Food, & Rural Affairs.
Mr. Day was previously employed as an Independent Non-Executive Director by Delinian Ltd., a Non-Executive Director-Environment & Food by FM Insurance Co. Ltd., a Non-Executive Director-Environment & Food by FM Insurance Europe SA, a Senior Independent Non-Executive Director by Amec Foster Wheeler Plc, a Non-Executive Director by Cadbury Plc, an Independent Non-Executive Director by WPP 2012 Ltd., an Independent Non-Executive Director by WPP Plc, a Non-Executive Director by Imperial Tobacco Group Plc, a Non-Executive Director by easyJet Plc, a Chief Financial Officer & Executive Director by Reckitt Benckiser Group Plc, a Non-Executive Director by Bell Security Ltd., a Non-Executive Director by Vero Group Plc, a Group Finance Director by Dentsu Aegis Network Ltd., a Group Finance Director by ABB Instrumentation Ltd., a Group Finance Director by ABB Kent (Holdings) Plc, a Group Financial Controller by Crosfield Electronics Ltd., a Group Financial Controller by New De La Rue Plc, a Finance Director by ABB Ltd., a Group Director-Finance by Aegis Group Plc, and a Non-Executive Director by WPP 2005 Ltd.
He also served on the board at Essentra Plc, E.R.
Howard Ltd., Essentra Finance Ltd., Essentra International Ltd.
and RB Holdings Finance (France) Ltd.
He received his MBA from Cranfield School of Management.

Colin K. Gruending è direttore finanziario e vicepresidente esecutivo di Enbridge, Inc. Il signor Gruending è anche nel consiglio di Gaz Mtro LNG LP e Noverco, Inc. Nella sua carriera passata è stato direttore finanziario per Enbridge Management Services, Inc. e direttore finanziario per Enbridge Income Fund Holdings, Inc. Si è laureato presso l'Università di Saskatchewan.

Colin Kincaid is currently the Chief Product Officer at Casa Systems, Inc. Prior to this, he worked as an Engineering Director at Cisco Systems, Inc. and Maker Communications, Inc. He also held Principal positions at Nexion, Inc., Xedia Corp., and ASCOM Corp.
Mr. Kincaid completed his undergraduate degree at Boston University.

Colin Bell è responsabile della conformità del gruppo presso HSBC Holdings Plc. Fa parte del consiglio di amministrazione di Quantexa Ltd. e HSBC Bank Plc. Il sig. Bell è stato precedentemente impiegato come Head-Compliance & Operational Risk Control presso UBS Ltd. e Global Head-Operational Risk Control presso UBS Reorganisation 2005-04 Ltd.

Colin Grahame Storrie è membro dell'Australian Institute of Co. Directors e fa parte del consiglio di amministrazione di altre 7 società. In passato è stato direttore finanziario di AMP Ltd. Direttore Esecutivo presso AMP Group Finance Services Ltd. e Direttore Finanziario di AMP Ltd. (Portafoglio investimenti). (Portafoglio d'investimento) (entrambe sono filiali di AMP Ltd.) e direttore finanziario di Qantas Airways Ltd. Storrie si è laureato presso l'Università di Wollongong.

Colin Browne è nel consiglio di amministrazione di Footwear Distributors & Retailers of America e presidente dell'American Apparel & Footwear Association e Chief Operating Officer di Under Armour, Inc. In passato il signor Browne ha occupato la posizione di vicepresidente e amministratore delegato presso VF Corp., amministratore delegato-Asia presso Pentland Brands Plc e vicepresidente esecutivo-Footwear & Accessories presso Fung Group.

Colin Black occupa la posizione di direttore operativo di CrowdStrike Holdings, Inc. e direttore operativo di CrowdStrike, Inc. (una filiale di CrowdStrike Holdings, Inc.). Il sig. Black è anche segretario e direttore di The Crowdstrike Foundation. Nella sua carriera passata ha ricoperto la posizione di Chief Information Officer presso Kratos Defense & Security Solutions, Inc. e Chief Information Officer di Cymer, Inc.

Colin Dyer è un uomo d'affari che ha fondato WorldWide Retail Exchange LLC e che è stato a capo di 6 diverse aziende. Il signor Dyer è nel consiglio di Altus Group Ltd., The Executives Club of Chicago, Paramount Group, Inc. e Unibail-Rodamco-Westfield SE (ex presidente del consiglio di sorveglianza) e membro del Chicago Club e membro della Royal Institution of Chartered Surveyors. In passato Colin Dyer ha ricoperto la carica di direttore non esecutivo presso Jones Lang LaSalle, Inc. e di amministratore delegato di Jones Lang LaSalle Americas, Inc. (una filiale di Jones Lang LaSalle, Inc.), Client Manager presso McKinsey & Co., Inc., Presidente del Consiglio di Sorveglianza di Unibail-Rodamco-Westfield NV, Amministratore Delegato di Courtaulds Textiles Plc e Amministratore Delegato di WorldWide Retail Exchange LLC. Il signor Dyer si è laureato all'Imperial College di Londra e ha conseguito un MBA all'INSEAD.

Attualmente, Colin Hunt occupa la posizione di amministratore delegato e direttore esecutivo presso AIB Group Plc e amministratore delegato e direttore presso Allied Irish Banks Plc. In precedenza ha ricoperto la posizione di Research Director presso Goodbody Stockbrokers ULC, Managing Director presso Macquarie Capital Ireland DAC e Head-Trading Research presso Bank of Ireland Group Treasury. Colin Hunt ha conseguito un dottorato presso lo University College Cork e una laurea presso il Trinity College di Dublino.

Attualmente, Colin Shannon è presidente, presidente e amministratore delegato di PRA Health Sciences, Inc. e presidente, presidente e amministratore delegato di Pharmaceutical Research Associates, Inc., presidente di PRA International Operations, Inc. e presidente di PRA Holdings, Inc. (che sono tutte filiali di PRA Health Sciences, Inc.). Fa anche parte del consiglio di Pharm Research Associates (UK) Ltd. e IMP Logistics UK Ltd. ed è Fellow Member presso l'Association of Chartered Certified Accountants. Colin Shannon ha occupato in precedenza la posizione di VP esecutivo-Global Clinical Operations presso Pharmaceutical Product Development LLC e VP esecutivo-Global Clinical Operations presso PPD Development LP. Ha conseguito una laurea e un MBA presso la City University di Londra.

Attualmente, Colin V. Reed è presidente e amministratore delegato di Ryman Hospitality Properties, Inc. È anche nel consiglio di amministrazione di First Horizon Corp. (Tennessee). Nella sua carriera passata ha ricoperto la posizione di presidente e amministratore delegato di Gaylord Entertainment Co., presidente di JCC Holding Co., direttore finanziario e vicepresidente esecutivo di Caesars License Co. LLC e assistente esecutivo di Holiday Corp.

Colin Naughton is currently the President-Asia Region at Autoliv, Inc. He previously served as the President at Autoliv Japan Ltd.
and Autoliv Thailand Ltd.
Mr. Naughton completed his undergraduate degree at the National University of Ireland Galway.

Colin Michael Penny is currently the Chief Information Officer & Senior VP-Technology at Hydro One Networks, Inc. He is also currently the Chief Information Officer at Algonquin Power & Utilities Corp.
Previously, he worked as the Director at Canadian Cyber Threat Exchange Cctx from 2016 to 2018.
He also held the position of Chief Information Officer & Senior VP-Technology at Hydro One, Inc. and Hydro One Ltd.
from 2009 to 2018.
Mr. Penny completed his undergraduate degree at Queen's University.

Colin L.
Simpson is currently the Chief Financial Officer at Manulife Financial Corp.
He previously worked as the Director-Investor Relations at Aviva Plc from 2013 to 2015, a Research Analyst at Goldman Sachs International from 2008 to 2013, and as the Chief Financial Officer at Aviva Plc in 2022.
He also worked as a Research Analyst at Bear Stearns International Ltd.
and as the Chief Financial Officer at Aviva Canada, Inc. Mr. Simpson completed his undergraduate degree at the University of Cape Town.

Amnon Goldschmidt is currently the Chairman of A.
Goldschmidt Investments Ltd., and a Director at Israel Mezzanine Fund LP, FIMI 2001 Ltd., and Harel Recanati Investment House Ltd.
He previously served as Chairman of Memador Ltd., and as a Director at First Israel Mezzanine Investors Ltd., Solbar Food Technologies Ltd., and FIMI Opportunity 2005 Ltd.
He was also an Independent Director at The First International Bank of Israel Ltd.
Dr. Goldschmidt holds a doctorate from Simon Fraser University, and undergraduate and MBA degrees from The Hebrew University of Jerusalem.

Luís Goldschmidt currently works as a Press Relations Contact for Caixa Geral de Depósitos SA.

Matthias Goldschmidt has a current job as a Member-Supervisory Board at Wohnungsbaugenossenschaft Schönebeck eG.

Mark R Goldschmidt is currently a Partner at Holland & Knight LLP, and a Member of both the Massachusetts Bar Association and The Colorado Bar Association.
He was previously a Principal at Patton Boggs LLP and an Infantry Officer in The United States Army (District of Columbia).
Goldschmidt received a graduate degree from Boston College in 2002.

Daniel Goldschmidt is currently a Director at Danish Aerospace Medical Co. A, M.
Goldschmidt Holding A, and Imerco Holding A.
He was formerly a Director at Aquaporin A.

Nils Goldschmidt is the founder and current Chief Executive Officer of Terra Exports LLC, which is founded in 2012.

Adam Goldschmidt has an undergraduate degree from Baruch College.

Steven Goldschmidt currently works at Real Estate Board of New York, Inc., as Member-the Executive Cmte & NYRS Masters Program.

Bradley Darrin Goldschmidt currently works at Global Life Distribution Holdings Ltd., as Director from 2014 and Global Life Distribution (UK)Ltd., as Director from 2014.

Stephen Goldschmidt has worked as an Investment Professional at KLAR Partners Ltd.
since 2022.

Mr. Goldschmidt was the co-founder of Yozma and the core of its management team since inception in January 1993.
Mr. Goldschmidt led many of Yozma's investments in Communications and Internet companies, including E-sim (NASDAQ: ESIM), CommTouch (NASDAQ: CTCH), Telegate (acquired by Terayon Communications, NASDAQ: TERN), HarmonyCom - recently received an investment from Cisco (NASDAQ: CSCO), and Trellis Photonics - recently received investment from Agilent (NYSE:A) and Enron (NYSE: ENE).
Prior to joining Yozma, Goldschmidt gained extensive experience as head of the Royalties Department at the Office of the Chief Scientist.
In this capacity Mr. Goldschmidt evaluated investments in hundreds of high-tech companies primarily in the fields of Communications, Software, and Microelectronics.
Mr.Goldschmidt served on Conduit's BOD and later as Conduit's VP Corp Dev.
He is an active investor and his recent investments include: Javelin Medical, Nova sight, Imvision technologies, Minovia Theraputics, Tingo Medical, Triple jump, Nanorep (Acquired by logmein).
Mr. Goldschmidt holds a BA degree in Economics and an MBA degree from the Hebrew University of Jerusalem.

Sophie Goldschmidt is currently the President & Chief Executive Officer at US Ski & Snowboard Team Foundation.
She is also a Director at Rugby International Marketing LLC, Cain Acquisition Corp., and a Governor at International Tennis Hall of Fame, Inc. Her former positions include Chief Executive Officer at Association of Surfing Professionals International LLC from 2017 to 2020, Non-Executive Director at Youth Sport Trust from 2012 to 2018, Group Managing Director at CSM Sport & Entertainment LLP, Non-Executive Director at PGA European Tour from 2012 to 2018, Vice President-Marketing & Sponsorships at Wta Tour, Inc., and Chief Commercial & Marketing Officer at Rugby Football Union from 2011 to 2016.
She received her undergraduate degree from Baylor University.

Mr. Eli Goldschmidt is Executive VP-Communications & Regulations at Israel Corp.
Ltd.
He received his graduate degree from Tel-Aviv University.

James E.
Goldschmidt is currently the President-United States at Sandoz, Inc. and the Chief Business Development Officer at CASI Pharmaceuticals, Inc. Previously, he held positions such as Executive Director-Business Development at Johnson & Johnson, Executive Director-Oncology New Business at Wyeth Pharmaceuticals LLC, Product Director at GSK Plc, and Senior Vice President-Business Development at CASI Pharmaceuticals, Inc. He also served as the Vice President-Business & Commercial Development at TetraLogic Pharmaceuticals Corp., Vice President-Business Development at ImmuneXcite, Inc., and Chief Operating Officer at Macrophage Therapeutics, Inc. Dr. Goldschmidt obtained a graduate degree from Drexel University, an undergraduate degree from Villanova University, and a doctorate degree from Temple University School of Medicine.

Lawrence E.
Goldschmidt is currently the Deputy Chairman at The Jewish Guild for the Blind.

Ms. Paula Goldschmidt is Vice President-Business Development at Liola Technologies Ltd.
Ms. Goldschmidt was previously employed as a Director-Technology & Business Development by Intel Corp.
She received her undergraduate degree from The Hebrew University of Jerusalem and a graduate degree from The Hebrew University of Jerusalem.

Andrew Goldschmidt worked as the Chief Customer Officer at Kenexa Corp.

Nils Goldschmidt currently works at Hamburgisches WeltWirtschaftsInstitut gemeinnützige GmbH, as Research Fellow.

Eliot Goldschmidt worked as a Director at Meridian Capital Group LLC from 2018 to 2021.

Oren Goldschmidt is currently a Managing Director at Pivotus, Inc. He was previously a Managing Director at Umpqua Holdings Corp.
where he worked for Pivotus Ventures Inc.

Jan Goldschmidt has a current job as a Member-Supervisory Board at Öffentliche Lebensversicherung Braunschweig.

Nathan Goldschmidt is a Member of The Institute of Chartered Accountants in Australia, and a former Chief Financial Officer at Ingenia Communities Group.
He completed his undergraduate degree at The University of New South Wales.

Lars Goldschmidt is currently the Chairman of Erhvervsskolernes Forlag, Deputy Chairman of Campus Bornholm, Chairman of Horsens Fjernvarme A, Chairman of TREFOR El-Net Øst A, Director of Bornholms Erhvervsfond, Deputy General Director of Dansk Industri Holding A, Director of VIA University College, Director of European Spallation Source ESS AB, Director of Copenhagen School of Design & Technology, Director of Kea Copenhagen School of Design & Technology, and Member of Danish Council For Technology & Innovation.
He is also a Partner at Goldschmidt Rise & Shine I.
In the past, he served as the Chief Executive Officer & Director of Monberg & Thorsen A, Chairman of the University of Copenhagen, Chairman of Bornholms Energi & Forsyning A, Deputy Director General of Confederation of Danish Industry, and Director of Østkraft A.
He holds a graduate and doctorate degree from the Technical University of Denmark.

Howard Goldschmidt currently works at American Committee for Shaare Zedek Hospital in Jerusalem, as President & Director.

David Goldschmidt worked as an Associate Director at Ripco Real Estate Corp.
from 2015 to 2019.